DexCom, Inc. stock research
FY2023 Q2
DexCom (DXCM) Gross Margin — Quarter Ended Jun 30, 2023
Revenue and gross profit both increased compared to the prior quarter and the same quarter last year. Gross margin improved sequentially but weakened year-over-year.
Gross margin takeaway
Quarter ended Jun 30, 2023 · FY2023 Q2
Revenue and gross profit both increased compared to the prior quarter and the same quarter last year. Gross margin improved sequentially but weakened year-over-year.
- Gross margin was higher quarter-over-quarter but lower than the year-ago period, reflecting a change in the relationship between cost of revenue and revenue.
- Compared to the prior quarter, gross margin improved; compared to the same quarter last year, gross margin decreased.
Gross margin snapshot
The selected quarter's reported revenue, gross profit, direct costs, and margin comparisons.
Gross margin
62.7%
Gross profit
$546.4M
Revenue
$871.3M
Cost of revenue
$324.9M
Quarter-over-quarter change
+0.3 pts
Year-over-year change
-1.9 pts
Quarterly gross margin trend
A four-quarter view of the revenue and direct-cost bridge behind gross margin.
| Period | Revenue | Gross profit | Cost of revenue | Gross margin |
|---|---|---|---|---|
| Mar 31, 2023 | $741.5M | $462.6M | $278.9M | 62.4% |
| Jun 30, 2023 | $871.3M | $546.4M | $324.9M | 62.7% |
Quarterly comparisons
Compare the selected margin with the preceding quarter and the same fiscal quarter one year earlier.
Previous-quarter change
Mar 31, 2023
+0.3 pts
Year-over-year change
Jun 30, 2022
-1.9 pts
What the margin says
Filing-constrained interpretation of margin direction, comparisons, and what to monitor next.
Gross margin was higher quarter-over-quarter but lower than the year-ago period, reflecting a change in the relationship between cost of revenue and revenue.
Compared to the prior quarter, gross margin improved; compared to the same quarter last year, gross margin decreased.
Monitor the direction of gross margin relative to revenue growth in upcoming quarters.